K.-L.G. Spindler

708 total citations
22 papers, 492 citations indexed

About

K.-L.G. Spindler is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, K.-L.G. Spindler has authored 22 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in K.-L.G. Spindler's work include Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Genomics and Diagnostics (6 papers). K.-L.G. Spindler is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Genomics and Diagnostics (6 papers). K.-L.G. Spindler collaborates with scholars based in Denmark, Sweden and United States. K.-L.G. Spindler's co-authors include Anders Jakobsen, Niels Pallisgaard, Rikke Fredslund Andersen, Ivan Brandslund, Jan Lindebjerg, John Pløen, Julia S. Johansen, Audrey Rasmussen, D. G. Crüger and Anders Kindberg Boysen and has published in prestigious journals such as PLoS ONE, Annals of Oncology and European Journal of Cancer.

In The Last Decade

K.-L.G. Spindler

20 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.-L.G. Spindler Denmark	11	362	225	174	154	98	22	492
Richard M. Goldberg United States	12	433 1.2×	214 1.0×	206 1.2×	201 1.3×	91 0.9×	33	644
Joana Vidal Spain	11	381 1.1×	364 1.6×	262 1.5×	174 1.1×	121 1.2×	29	596
Margarita Reboredo Spain	13	304 0.8×	204 0.9×	70 0.4×	156 1.0×	206 2.1×	31	553
Sonia Candamio Spain	9	349 1.0×	306 1.4×	180 1.0×	155 1.0×	111 1.1×	22	488
S. Peter Eggleton Germany	9	418 1.2×	310 1.4×	132 0.8×	116 0.8×	63 0.6×	21	618
Fabienne Portales France	13	523 1.4×	182 0.8×	66 0.4×	236 1.5×	72 0.7×	31	596
Rosario Alfonso Spain	6	389 1.1×	191 0.8×	93 0.5×	142 0.9×	77 0.8×	15	461
Kåre Andersson Gotschalck Denmark	11	261 0.7×	222 1.0×	151 0.9×	116 0.8×	146 1.5×	33	519
Kentaro Sawada Japan	12	423 1.2×	173 0.8×	164 0.9×	309 2.0×	80 0.8×	59	633
Toshiro Ogura Japan	11	270 0.7×	140 0.6×	69 0.4×	162 1.1×	206 2.1×	45	554

Countries citing papers authored by K.-L.G. Spindler

Since Specialization

Citations

This map shows the geographic impact of K.-L.G. Spindler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-L.G. Spindler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-L.G. Spindler more than expected).

Fields of papers citing papers by K.-L.G. Spindler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.-L.G. Spindler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-L.G. Spindler. The network helps show where K.-L.G. Spindler may publish in the future.

Co-authorship network of co-authors of K.-L.G. Spindler

This figure shows the co-authorship network connecting the top 25 collaborators of K.-L.G. Spindler. A scholar is included among the top collaborators of K.-L.G. Spindler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-L.G. Spindler. K.-L.G. Spindler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spindler, K.-L.G., et al.. (2025). Lower urinary tract sub-structures as predictors of late urinary toxicity in concurrent chemo-radiotherapy for anal cancer. Radiotherapy and Oncology. 204. 110708–110708.

Samuel, Robert, Morten Busk, Glen Guerra, et al.. (2025). Biological features of squamous cell carcinoma of the anus—a deep dive review. Scopus (Elsevier). 100157–100157.

Nadzieja, Marcin, Zhongyang Zhang, Yingchun Su, et al.. (2020). A melt-electrowritten filter for capture and culture of circulating colon cancer cells. Materials Today Bio. 6. 100052–100052. 14 indexed citations

Hamfjord, Julian, Tormod Kyrre Guren, Olav Dajani, et al.. (2019). Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy. Annals of Oncology. 30(7). 1088–1095. 57 indexed citations

Boysen, Anders Kindberg, Brita Singers Sørensen, Julia S. Johansen, et al.. (2018). Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer. Clinica Chimica Acta. 487. 107–111. 12 indexed citations

Schou, Jakob Vasehus, Finn Ole Larsen, Brita Singers Sørensen, et al.. (2017). Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer. Annals of Oncology. 29(3). 610–615. 59 indexed citations

Appelt, Ane, Femke P. Peters, J. Lilley, et al.. (2017). EP-1748: Mesorectal-only irradiation for early stage rectal cancer: Target volumes and dose to organs at risk. Radiotherapy and Oncology. 123. S962–S963. 1 indexed citations

Jensen, Benny Vittrup, K.-L.G. Spindler, Ib Jarle Christensen, et al.. (2016). Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan. Annals of Oncology. 27. vi29–vi29. 1 indexed citations

Demuth, Christina, et al.. (2016). P-007 Comparison of methods for measuring total cell-free DNA and KRAS mutations in plasma from metastatic colorectal cancer patients. Annals of Oncology. 27. ii2–ii2. 1 indexed citations

10.

Spindler, K.-L.G., Anders Kindberg Boysen, Julia S. Johansen, et al.. (2016). A systematic review and meta-analysis of the prognostic value of total cell-free DNA quantification in metastatic colorectal cancer. Annals of Oncology. 27. vi187–vi187. 1 indexed citations

11.

Spindler, K.-L.G., Niels Pallisgaard, Rikke Fredslund Andersen, Ivan Brandslund, & Anders Jakobsen. (2015). Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer. PLoS ONE. 10(4). e0108247–e0108247. 110 indexed citations

12.

Pløen, John, et al.. (2014). PO-1041: MRI-guided brachytherapy for rectal cancer: A treatment planning study with a shieldable multicatheter applicator. Radiotherapy and Oncology. 111. S160–S160. 1 indexed citations

13.

Spindler, K.-L.G., Niels Pallisgaard, Rikke Fredslund Andersen, John Pløen, & Anders Jakobsen. (2014). Gemcitabine and capecitabine for heavily pre-treated metastatic colorectal cancer patients--a phase II and translational research study.. PubMed. 34(2). 845–50. 14 indexed citations

14.

Johnsson, Anna, Helga Hagman, Jan‐Erik Frödin, et al.. (2013). A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial. Annals of Oncology. 24(9). 2335–2341. 59 indexed citations

15.

Pallisgaard, Niels, Rikke Fredslund Andersen, K.-L.G. Spindler, Ivan Brandslund, & Anders Jakobsen. (2013). MC13-0088 Controls for quantification of total cell free DNA qPCR analyses in plasma. European Journal of Cancer. 49. S36–S36. 3 indexed citations

16.

Hansen, Torben Frøstrup, Lars Henrik Jensen, K.-L.G. Spindler, et al.. (2010). The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer. Colorectal Disease. 13(9). 984–988. 6 indexed citations

17.

Spindler, K.-L.G., Niels Pallisgaard, Audrey Rasmussen, et al.. (2009). The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. Annals of Oncology. 20(5). 879–884. 63 indexed citations

18.

Glimelius, Bengt, Michael Lahn, Ann Cleverly, et al.. (2009). A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer. Annals of Oncology. 21(5). 1020–1026. 22 indexed citations

19.

Spindler, K.-L.G., Rikke Fredslund Andersen, Lars Henrik Jensen, John Pløen, & Anders Jakobsen. (2009). EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer. Annals of Oncology. 21(3). 535–539. 24 indexed citations

20.

Lindebjerg, Jan, K.-L.G. Spindler, John Pløen, & Anders Jakobsen. (2008). The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long‐course preoperative chemoradiotherapy. Colorectal Disease. 11(3). 264–269. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact